Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer

Area of Science:

• Epigenetics
• Cancer Biology
• Genomics

Background:

• Epigenetic alterations are fundamental in cancer development.
• Histone 3 acetylation at lysine 27 (H3K27ac) marks active genes.
• Limited H3K27ac data exists for primary tumors compared to cell lines.

Purpose of the Study:

• To investigate cancer-specific H3K27ac alterations in primary rectal cancer.
• To assess the feasibility of ChIP-seq for epigenome mapping in primary tumors.
• To identify potential gene expression biomarkers associated with H3K27ac changes.

Main Methods:

• Chromatin immunoprecipitation followed by sequencing (ChIP-seq) for H3K27ac.
• Analysis of tissue samples from primary rectal cancer and matched adjacent mucosa.
• Gene expression analysis and immunohistochemistry on independent patient cohorts.

Main Results:

• Successful ChIP-seq for H3K27ac in primary rectal cancer and matched mucosa.
• Identification of 44 differentially occupied H3K27ac regions.
• Upregulation of RIPK2, FOXQ1, KRT23, and EPHX4 linked to increased H3K27ac in tumors.

Conclusions:

• ChIP-seq is feasible for epigenome mapping in primary rectal cancer.
• H3K27ac occupancy accurately predicts gene expression differences.
• Identified genes (RIPK2, FOXQ1, KRT23, EPHX4) are potential biomarkers for rectal cancer.